Company News

Share this article:

Contract sales firm PDI announced new business wins exceeding $18 million, but would not divulge the new clients' names, based on contractual agreements, according to a spokesperson. The contracts include primary care, specialty and hospital settings sales teams, according to a statement. Reps will be deployed in June, and will call on hospital-based physicians specializing in women's health, primary care and pediatrics.

 

Eloquest Healthcare, a dermatology specialty company, partnered with Onset Therapeutics to market Optase, a topical prescription product for the treatment of decubitus ulcers, varicose ulcers and dehiscent wounds. Optase is one of two products joint-marketed by Onset Therapeutics and Eloquest Healthcare – the second is Exactacain, a topical anesthetic spray.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions